Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 528 companies set new 52-week lows.
HC Wainwright & Co. Maintains Buy on KalVista Pharma, Lowers Price Target to $16
HC Wainwright & Co. analyst Andrew Fein maintains KalVista Pharma (NASDAQ:KALV) with a Buy and lowers the price target from $48 to $16.
SVB Leerink Maintains Outperform on KalVista Pharma, Lowers Price Target to $30
SVB Leerink analyst Joseph Schwartz maintains KalVista Pharma (NASDAQ:KALV) with a Outperform and lowers the price target from $45 to $30.
S&P 500 Rises 100 Points; Nasdaq Up 3%
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing more than 300 points on Tuesday.
Nasdaq Surges 250 Points; Crude Oil Rises Sharply
U.S. stocks traded higher midway through trading, with the Nasdaq Composite climbing more than 250 points on Tuesday.